Now, as new iterations or combinations of antiretrovirals (ARVs) emerge from drug-company pipelines, STRs are not only sustaining high levels of efficacy, but they are also getting better tolerated.

[Benjamin Sakwa, Standard] The investigating team carrying out clinical studies for the injectable ARVs has started lobbying ... insights on the treatment regime comparing this to what is ...

The minister of health Aaron Motsoaledi has urged South Africans who are living with HIV/Aids to continue taking their ARVS amid the pausing ... in an increase in new infections and fatalities ...